FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076390969> ?p ?o ?g. }

• W2076390969 endingPage "1551" @default.
• W2076390969 startingPage "1544" @default.
• W2076390969 abstract "Atherothrombosis of the coronary and cerebral vessels is understood to be a disorder of inflammation and innate immunity, as well as a disorder of lipid accumulation. From a vascular biology perspective, the processes of cellular adhesion, monocyte and macrophage attachment, and transmigration of immune cells across the endothelium are crucial steps in early atherogenesis and in the later stages of mature plaque rupture, particularly the transition of unstable plaque at the time of acute thrombosis. There is abundant clinical evidence demonstrating that many biomarkers of inflammation are elevated years in advance of first ever myocardial infarction (MI) or thrombotic stroke and that these same biomarkers are highly predictive of recurrent MI, recurrent stroke, diabetes, and cardiovascular death. In daily practice, the inflammatory biomarker in widest use is high-sensitivity C-reactive protein (hsCRP); when interpreted within the context of usual risk factors, levels of hsCRP <1, 1 to 3, and >3 mg/l denote lower, average, and higher relative risk for future vascular events. Risk-prediction models that incorporate hsCRP, such as the Reynolds Risk Score, have been developed that improve risk classification and the accuracy for global risk prediction, particularly for those deemed at intermediate risk by usual algorithms, such as the Framingham Risk Score. With regard to cerebral vessels, increased biomarkers of inflammation, including hsCRP, have been associated with increased stroke risk as well as an increased rate of atherosclerosis progression in the carotid vessels. Although the proportion of variation in hsCRP explained by genetic factors may be as large as 20% to 40%, diet, exercise, and smoking cessation remain critical tools for risk reduction and CRP reduction. Statin therapy reduces hsCRP in a largely low-density lipoprotein (LDL)-independent manner, and the anti-inflammatory properties of these agents have been suggested as a potential mechanism beyond LDL reduction for the efficacy of these agents. The ongoing multinational Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial of 17,802 initially healthy men and women with low levels of LDL cholesterol but increased levels of hsCRP will help to define whether vascular protection can be achieved with statin therapy, even in the absence of hyperlipidemia. Targeted anti-inflammatory therapies are being developed that may provide a direct method of translating the biology of inflammation into new clinical treatments across multiple vascular beds. This article summarizes data supporting a role for inflammation in cardiovascular disease and offers the possibility that other disorders characterized by inflammation, such as periodontal disease, may have an indirect role by influencing the risk, manifestation, and progression of vascular events." @default.
• W2076390969 created "2016-06-24" @default.
• W2076390969 creator A5078905537 @default.
• W2076390969 creator A5091595592 @default.
• W2076390969 date "2008-08-01" @default.
• W2076390969 modified "2023-10-14" @default.
• W2076390969 title "Inflammation, C‐Reactive Protein, and Atherothrombosis" @default.
• W2076390969 cites W1499548788 @default.
• W2076390969 cites W1552103637 @default.
• W2076390969 cites W1964291828 @default.
• W2076390969 cites W1976077702 @default.
• W2076390969 cites W1981851376 @default.
• W2076390969 cites W1984797067 @default.
• W2076390969 cites W1985967126 @default.
• W2076390969 cites W1986349550 @default.
• W2076390969 cites W1987709455 @default.
• W2076390969 cites W1991405020 @default.
• W2076390969 cites W1994324030 @default.
• W2076390969 cites W1995702870 @default.
• W2076390969 cites W1997443963 @default.
• W2076390969 cites W2000869225 @default.
• W2076390969 cites W2007272726 @default.
• W2076390969 cites W2018135697 @default.
• W2076390969 cites W2019358153 @default.
• W2076390969 cites W2031350146 @default.
• W2076390969 cites W2032485049 @default.
• W2076390969 cites W2036932056 @default.
• W2076390969 cites W2058324403 @default.
• W2076390969 cites W2058610272 @default.
• W2076390969 cites W2063058274 @default.
• W2076390969 cites W2072005929 @default.
• W2076390969 cites W2072656254 @default.
• W2076390969 cites W2073040540 @default.
• W2076390969 cites W2074035141 @default.
• W2076390969 cites W2079168568 @default.
• W2076390969 cites W2080883999 @default.
• W2076390969 cites W2087287221 @default.
• W2076390969 cites W2090131432 @default.
• W2076390969 cites W2099087060 @default.
• W2076390969 cites W2100419955 @default.
• W2076390969 cites W2106343349 @default.
• W2076390969 cites W2108139718 @default.
• W2076390969 cites W2108324242 @default.
• W2076390969 cites W2111787028 @default.
• W2076390969 cites W2112720813 @default.
• W2076390969 cites W2115004354 @default.
• W2076390969 cites W2118154631 @default.
• W2076390969 cites W2119475547 @default.
• W2076390969 cites W2121893515 @default.
• W2076390969 cites W2126882682 @default.
• W2076390969 cites W2142179136 @default.
• W2076390969 cites W2146456234 @default.
• W2076390969 cites W2163092745 @default.
• W2076390969 cites W2165999166 @default.
• W2076390969 cites W2316376271 @default.
• W2076390969 cites W2340084730 @default.
• W2076390969 cites W4238251256 @default.
• W2076390969 doi "https://doi.org/10.1902/jop.2008.080249" @default.
• W2076390969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18673009" @default.
• W2076390969 hasPublicationYear "2008" @default.
• W2076390969 type Work @default.
• W2076390969 sameAs 2076390969 @default.
• W2076390969 citedByCount "232" @default.
• W2076390969 countsByYear W20763909692012 @default.
• W2076390969 countsByYear W20763909692013 @default.
• W2076390969 countsByYear W20763909692014 @default.
• W2076390969 countsByYear W20763909692015 @default.
• W2076390969 countsByYear W20763909692016 @default.
• W2076390969 countsByYear W20763909692017 @default.
• W2076390969 countsByYear W20763909692018 @default.
• W2076390969 countsByYear W20763909692019 @default.
• W2076390969 countsByYear W20763909692020 @default.
• W2076390969 countsByYear W20763909692021 @default.
• W2076390969 countsByYear W20763909692022 @default.
• W2076390969 countsByYear W20763909692023 @default.
• W2076390969 crossrefType "journal-article" @default.
• W2076390969 hasAuthorship W2076390969A5078905537 @default.
• W2076390969 hasAuthorship W2076390969A5091595592 @default.
• W2076390969 hasConcept C11783203 @default.
• W2076390969 hasConcept C126322002 @default.
• W2076390969 hasConcept C127413603 @default.
• W2076390969 hasConcept C134018914 @default.
• W2076390969 hasConcept C151730666 @default.
• W2076390969 hasConcept C164705383 @default.
• W2076390969 hasConcept C2776914184 @default.
• W2076390969 hasConcept C2779134260 @default.
• W2076390969 hasConcept C2779343474 @default.
• W2076390969 hasConcept C2780645631 @default.
• W2076390969 hasConcept C2781195455 @default.
• W2076390969 hasConcept C2781197716 @default.
• W2076390969 hasConcept C500558357 @default.
• W2076390969 hasConcept C55493867 @default.
• W2076390969 hasConcept C555293320 @default.
• W2076390969 hasConcept C71924100 @default.
• W2076390969 hasConcept C78519656 @default.
• W2076390969 hasConcept C86803240 @default.
• W2076390969 hasConceptScore W2076390969C11783203 @default.
• W2076390969 hasConceptScore W2076390969C126322002 @default.

• next